Two UN Agencies Come Out In Support Of Extension Of TRIPS LDC Waiver

medicines mixed

The United Nations Development Programme and the Joint UN Programme on HIV/AIDS have issued a joint statement supporting a request by least-developed countries to extend a waiver allowing them to abstain from enforcing patents on pharmaceutical products.

Five Challenges Filed Against Gilead Patent Claims For Hepatitis C Drug

Sovaldi

Pharmaceutical company Gilead Sciences has been noted first for developing a treatment for hepatitis C, which afflicts tens of millions around the world, and then for pricing it at jaw-dropping prices ($1000 per pill) in the United States and elsewhere. Now a group of health advocates has challenged Gilead’s patent applications in five emerging economies.

Did The WHO Just Invite Corporates To Set Health Policy?

wha-67-opening

From the New Minute: The Director General of the World Health Organisation (WHO) Dr. Margaret Chan has invited the private sector, civil society and academia among others, to join a dialogue on how non-state players can work with the global body to enhance public health work. A leading voice in this configuration is the United States-based Global Health Council (GHC) whose strong and spirited response to the invitation has set the cat among the pigeons in some countries (including reportedly with India) and certain sections of non-governmental organisations (NGOs).

At WIPO Event, Music Creators Tell Of Desperate Economic Times

IP Day 2015

NEW YORK – Musicians, songwriters, and producers recently gathered at a World Intellectual Property Organization event here and gave a stark depiction of a broken system that is not working for them financially, putting the very future of music-making at risk.

United States Hopeful Lisbon Members Will Open Diplomatic Conference To All

US mission geneva

During a press briefing today the United States said they still have hope that the 28 members of a World Intellectual Property Organization-administered treaty will let the whole WIPO membership participate in next week’s negotiations to amend that treaty. It said that the potential new treaty protecting appellations of origins and set to include geographical indications can impact the economies of many non-member countries.

Industry Asks For Clarity On LDC Request To Extend TRIPS Pharma Waiver

medicines for poor

Least developed countries (LDCs) at the World Trade Organization have requested that a waiver allowing them to not enforce intellectual property rights on pharmaceutical products be extended beyond its deadline of 1 January 2016. The brand pharmaceutical industry this week stated that it supports access to medicines for LDCs but does not see the need for this extension as LDCs already benefit from a WTO waiver on all products until 2021.

Pharma Offers View On How To Slow Antimicrobial Resistance, Boost Research

Bacteria

the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) provided its recommendations on how to slow down antimicrobial resistance and boost antibiotic research and development. In addition, the association organised a forum on the subject today.

UAEM Grades US Universities On Research For Neglected Diseases. Spoiler Alert – There’s Room For Improvement

UAEMLogo-2013

Universities play an enormous role in biomedical research in the United States, but are not doing all they can to advance research for neglected diseases or make their innovations available to people who need them most, the student groupUniversities Allied for Essential Medicines (UAEM) said this week. UAEM released the results of its second annual […]

Geographical Indications An Engine For Development, EU Panellists Say At WIPO

Penja Pepper

Geographical indications can provide socio-economic benefits for developing countries, said speakers at a side event to the World Intellectual Property Organization Committee on Development and Intellectual Property (CDIP) this week.

UK Industry Group Details Goals For Global Patent Harmonisation

UKIPO patent harmonisation

In recent months, intellectual property rights holder groups and northern governments have been stepping up their focus on harmonising international patent law to ease procedures and lower costs. Today, an industry group in the United Kingdom articulated some of those aims.